Thus, the study further promotes: i) role of Th-cell-derived GM-CSF and SC cell-derived chemokines in development of autoimmune neuroinflammation, and ii) these molecules as putative targets in therapy of MS, and most likely some other autoimmune inflammatory diseases. The gene discussed is CSF2; the disease is myeloid sarcoma.